サマリー

リキッドバイオプシーの世界市場 2023-2027
リキッドバイオプシー市場は2022-2027年に21億6839万米ドル成長し、予測期間中のCAGRは19.54%で加速すると予測される。当レポートでは、リキッドバイオプシー市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がん罹患率の増加、がん治療における個別化医療への注目の高まり、リキッドバイオプシー技術の進歩によって牽引されています。
Technavioのリキッドバイオプシー市場は以下のように区分される：
用途別
- がんアプリケーション
- 非がん用途
技術別
- CTCおよびctDNA
- エクソソームとRNA
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のリキッドバイオプシー市場の成長を促進する主な理由の一つとして、リキッドバイオプシーへの資金/投資の増加を挙げている。また、学術機関、産業界、M&A間の戦略的提携やリキッドバイオプシーの新たな応用が市場の大きな需要につながる。
リキッドバイオプシー市場に関するレポートは以下の分野をカバーしています：
- リキッド生検市場の規模
- リキッド生検市場予測
- リキッドバイオプシー市場の業界分析
本レポートでは、リキッドバイオプシー市場の主要ベンダーの詳細な分析を掲載しています。Menarini Industrie Farmaceutiche Riunite Srl、ANGLE Plc、Bio Rad Laboratories Inc.、Bio Techne Corp.、Biocept Inc.、Biodesix Inc.、CellMax Inc.、CIRCULOGENE、Exact Sciences Corp.、F. Hoffmann La Roche Ltd.、Guardant Health Inc.、Illumina Inc.、Inivata Ltd.、MDXHEALTH SA、Mesa Laboratories Inc.、Myriad Genetics Inc.、Novogene Co.Ltd.、OncoCyte Corp.、QIAGEN NV、SAGA Diagnostics AB。また、リキッドバイオプシー市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/liquid-biopsy-market-industry-size-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global liquid biopsy market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 Technology Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Cancer applications - Market size and forecast 2022-2027
o Exhibit 34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%)
o 6.4 Non-cancer applications - Market size and forecast 2022-2027
o Exhibit 38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Application
o Exhibit 42: Market opportunity by Application ($ million)
o Exhibit 43: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 44: Chart on Technology - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Technology - Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 46: Chart on Comparison by Technology
o Exhibit 47: Data Table on Comparison by Technology
o 7.3 CTC and ctDNA - Market size and forecast 2022-2027
o Exhibit 48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
o 7.4 Exosome and RNA - Market size and forecast 2022-2027
o Exhibit 52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Technology
o Exhibit 56: Market opportunity by Technology ($ million)
o Exhibit 57: Data Table on Market opportunity by Technology ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
o Exhibit 107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
o Exhibit 108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
o Exhibit 109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
o 12.4 ANGLE Plc
o Exhibit 110: ANGLE Plc - Overview
o Exhibit 111: ANGLE Plc - Product / Service
o Exhibit 112: ANGLE Plc - Key offerings
o 12.5 Bio Techne Corp.
o Exhibit 113: Bio Techne Corp. - Overview
o Exhibit 114: Bio Techne Corp. - Business segments
o Exhibit 115: Bio Techne Corp. - Key news
o Exhibit 116: Bio Techne Corp. - Key offerings
o Exhibit 117: Bio Techne Corp. - Segment focus
o 12.6 Biocept Inc.
o Exhibit 118: Biocept Inc. - Overview
o Exhibit 119: Biocept Inc. - Product / Service
o Exhibit 120: Biocept Inc. - Key offerings
o 12.7 Biodesix Inc.
o Exhibit 121: Biodesix Inc. - Overview
o Exhibit 122: Biodesix Inc. - Product / Service
o Exhibit 123: Biodesix Inc. - Key offerings
o 12.8 CellMax Inc.
o Exhibit 124: CellMax Inc. - Overview
o Exhibit 125: CellMax Inc. - Product / Service
o Exhibit 126: CellMax Inc. - Key offerings
o 12.9 CIRCULOGENE
o Exhibit 127: CIRCULOGENE - Overview
o Exhibit 128: CIRCULOGENE - Product / Service
o Exhibit 129: CIRCULOGENE - Key offerings
o 12.10 Exact Sciences Corp.
o Exhibit 130: Exact Sciences Corp. - Overview
o Exhibit 131: Exact Sciences Corp. - Product / Service
o Exhibit 132: Exact Sciences Corp. - Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 Guardant Health Inc.
o Exhibit 138: Guardant Health Inc. - Overview
o Exhibit 139: Guardant Health Inc. - Product / Service
o Exhibit 140: Guardant Health Inc. - Key news
o Exhibit 141: Guardant Health Inc. - Key offerings
o 12.13 Illumina Inc.
o Exhibit 142: Illumina Inc. - Overview
o Exhibit 143: Illumina Inc. - Business segments
o Exhibit 144: Illumina Inc. - Key news
o Exhibit 145: Illumina Inc. - Key offerings
o Exhibit 146: Illumina Inc. - Segment focus
o 12.14 MDXHEALTH SA
o Exhibit 147: MDXHEALTH SA - Overview
o Exhibit 148: MDXHEALTH SA - Product / Service
o Exhibit 149: MDXHEALTH SA - Key offerings
o 12.15 Myriad Genetics Inc.
o Exhibit 150: Myriad Genetics Inc. - Overview
o Exhibit 151: Myriad Genetics Inc. - Product / Service
o Exhibit 152: Myriad Genetics Inc. - Key offerings
o 12.16 QIAGEN NV
o Exhibit 153: QIAGEN NV - Overview
o Exhibit 154: QIAGEN NV - Product / Service
o Exhibit 155: QIAGEN NV - Key news
o Exhibit 156: QIAGEN NV - Key offerings
o 12.17 SAGA Diagnostics AB
o Exhibit 157: SAGA Diagnostics AB - Overview
o Exhibit 158: SAGA Diagnostics AB - Product / Service
o Exhibit 159: SAGA Diagnostics AB - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 160: Inclusions checklist
o Exhibit 161: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 162: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 163: Research methodology
o Exhibit 164: Validation techniques employed for market sizing
o Exhibit 165: Information sources
o 13.5 List of abbreviations
o Exhibit 166: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Technology - Market share 2022-2027 (%)
Exhibits45: Data Table on Technology - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Technology
Exhibits47: Data Table on Comparison by Technology
Exhibits48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Technology ($ million)
Exhibits57: Data Table on Market opportunity by Technology ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibits108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibits109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
Exhibits110: ANGLE Plc - Overview
Exhibits111: ANGLE Plc - Product / Service
Exhibits112: ANGLE Plc - Key offerings
Exhibits113: Bio Techne Corp. - Overview
Exhibits114: Bio Techne Corp. - Business segments
Exhibits115: Bio Techne Corp. - Key news
Exhibits116: Bio Techne Corp. - Key offerings
Exhibits117: Bio Techne Corp. - Segment focus
Exhibits118: Biocept Inc. - Overview
Exhibits119: Biocept Inc. - Product / Service
Exhibits120: Biocept Inc. - Key offerings
Exhibits121: Biodesix Inc. - Overview
Exhibits122: Biodesix Inc. - Product / Service
Exhibits123: Biodesix Inc. - Key offerings
Exhibits124: CellMax Inc. - Overview
Exhibits125: CellMax Inc. - Product / Service
Exhibits126: CellMax Inc. - Key offerings
Exhibits127: CIRCULOGENE - Overview
Exhibits128: CIRCULOGENE - Product / Service
Exhibits129: CIRCULOGENE - Key offerings
Exhibits130: Exact Sciences Corp. - Overview
Exhibits131: Exact Sciences Corp. - Product / Service
Exhibits132: Exact Sciences Corp. - Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. - Overview
Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits135: F. Hoffmann La Roche Ltd. - Key news
Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits138: Guardant Health Inc. - Overview
Exhibits139: Guardant Health Inc. - Product / Service
Exhibits140: Guardant Health Inc. - Key news
Exhibits141: Guardant Health Inc. - Key offerings
Exhibits142: Illumina Inc. - Overview
Exhibits143: Illumina Inc. - Business segments
Exhibits144: Illumina Inc. - Key news
Exhibits145: Illumina Inc. - Key offerings
Exhibits146: Illumina Inc. - Segment focus
Exhibits147: MDXHEALTH SA - Overview
Exhibits148: MDXHEALTH SA - Product / Service
Exhibits149: MDXHEALTH SA - Key offerings
Exhibits150: Myriad Genetics Inc. - Overview
Exhibits151: Myriad Genetics Inc. - Product / Service
Exhibits152: Myriad Genetics Inc. - Key offerings
Exhibits153: QIAGEN NV - Overview
Exhibits154: QIAGEN NV - Product / Service
Exhibits155: QIAGEN NV - Key news
Exhibits156: QIAGEN NV - Key offerings
Exhibits157: SAGA Diagnostics AB - Overview
Exhibits158: SAGA Diagnostics AB - Product / Service
Exhibits159: SAGA Diagnostics AB - Key offerings
Exhibits160: Inclusions checklist
Exhibits161: Exclusions checklist
Exhibits162: Currency conversion rates for US$
Exhibits163: Research methodology
Exhibits164: Validation techniques employed for market sizing
Exhibits165: Information sources
Exhibits166: List of abbreviations